Absence of mutations in the RET gene in acute myeloid leukemia
β Scribed by M. Visser; R. M. W. Hofstra; R. P. Stulp; Y. Wu; C. H. C. M. Buys; R. Willemze; J. E. Landegent
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 933 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Mutations at codon I 2, I 3, and 6 I of the HRAS, KRAS, and NRASgenes were evaluated in 99 cases of pediatric acute myeloid leukemia (AML) using oligonucleotide hybridization to polymerase chain reacted derived products. Twenty-four mutations were identified in the NRAS gene, I 3 in the KRAS gene, a
## Abstract The __AML1__ gene encodes a transcription factor that, together with its heterodimeric partner CBFB, regulates a number of target genes that are essential for normal hemopoiesis. In acute myeloid leukemia (AML), __AML1__ is disrupted not only by chromosomal translocations but also by mu
Recognition of specific skin manifestations of acute myelogenous leukemia is important because they have prognostic value and always indicates poor prognosis. P074 Jumping translocation of 1q in a case of childhood acute lymphoblastic leukemia, type L3 with t(8;14
## Abstract Gene amplification is a relatively rare event in acute myeloid leukemia (AML). Double minutes (dmin) and homogeneously staining regions are well established phenomena as cytogenetic correlates of gene amplification. Recently, however, two additional mechanisms leading to gene amplificat